1. Molecular etiology of deafness and cochlear implantation performances in the postlingually deafened cochlear implantees.
- Author
-
Park, H. -R., Shim, Y. J., Cho, D. T., Han, J. H., Kim, A. R., Kim, M. Y., Oh, J., Song, J. -J., Ko, J. -W., Lee, S., Oh, D. -Y., and Choi., B. Y.
- Subjects
CONFERENCES & conventions ,COCHLEAR implants ,DEAFNESS ,TREATMENT effectiveness - Abstract
Objective: To investigate the molecular etiology of deafness in the postlingually deafened cochlear implantees and determine whether CI performances are affected by the genetic etiologies Materials and methods: Seventy-four postlingually deafened patients who had undergone CI between January 2010 and March 2017 at Seoul National University Hospital and Seoul National University Bundang Hospital were included in the study. Among them, thirty-nine patients were consented to molecular genetic testing(MGT). Molecular genetic etiologies were assessed by Sanger sequencing in patients with a characteristic phenotypic marker. The rest of patients were tested with either panel sequencing or whole exome sequencing. Patients underwent MGT were allocated to the following groups depending on whether the genetic etiology was disclosed or not; "Genetically diagnosed(GD)", "Genetically undiagnosed(GUD)". Patients who did not undergo MGT and who had a shorter deaf duration than 6 years were identified as controls. Speech perception performance was assessed using K-CID sentence score, pre- and post-operative 3, 6, and 12months. Non-parametric testing was performed using Kruskal- Wallis test with post-hoc testing using Mann-Whitney U test with Bonferroni's correction. P<0.05 was considered significant. Results: Among the thirty-nine postlingually deafened cochlear implantees who underwent MGT, 20 patients (51%) turned out to have a conclusive Mendelian genetic etiology, leaving the other 19 patients (49%) undiagnosed. Such an extreme molecular etiologic heterogeneity as to involve 13 deafness genes was noted for this cohort. To interest, about half of the postlingually deafened genetic cases were due to autosomal recessive variants which were previously thought to causes mainly prelingual deafness. The most frequent causative gene was TMC1 (DFNA36) (3 cases), followed by the next tier of genes (2 cases each) (ACTG1, CDH23, COCH, SLC26A4, TMPRSS3) and the genes that were detected only once (ATP1A3, GJB2, ILDR1, MYO7A, NF2, OTOR and SERPNB6). All of these genes are expressed in membranous labyrinth(ML), except TMPRSS3 which is expressed abundantly in spiral ganglion neurons(SGN). The median ages of the GD, GUD and control groups were all younger than 55 years and the median deaf durations of the GD, GUD and control groups were all shorter than 5 years. Post-operative Spondee, PB word score and K-CID scores at 3months, 6months and 12months of the three groups overall did not show statistically significant differences, all reaching about at least 70% for K-CID scores at 1 year. Rising trends in Spondee word scores and KCID scores of GD group at 3 months after CI tend to show slightly heavier, albeit statistically insignificant, than those of GUD group. Among the GD groups, there was no significant difference of speech perception performance between the groups of genes expressing in the SGN and genes expressed in the ML. Although most of the genetically diagnosed cases showed relatively good speech perception performances, two patients who had ACTG1 mutation and each one of the patients who had SLC26A4, CDH23, TMC1, TMPRSS3 and OTOR mutations had post-operative K-CID scores below interquartile range of control group. Among them, two patients with ACTG1 mutation and one of the patients with TMC1 mutation who had deaf durations over 10 years showed KCID scores under 50% a year after CI. Conclusion: Our genetic diagnosis rate was 51% in postlingually deafened cochlear implantees and a wide variety of causative genes have been found. Cochlear implantees who were genetically diagnosed showed speech perception performances comparable to the control group, even in the genes expressed in SGN. However, even with the same causative mutation, those with significantly longer deaf duration are associated with relatively worse performance, mandating prompt implantation, if indicated. [ABSTRACT FROM AUTHOR]
- Published
- 2018